Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.733 USD | +0.04% | -44.80% | -93.14% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 226K |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -28M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.28
x | P/E ratio 2025 * |
-0.47
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Allarity Therapeutics, Inc.
1 day | -18.68% | ||
1 week | -42.31% | ||
Current month | -42.31% | ||
1 month | -83.79% | ||
3 months | -92.04% | ||
6 months | -92.82% | ||
Current year | -93.35% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jensen
FOU | Founder | 46 | 20-05-31 |
Joan Brown
DFI | Director of Finance/CFO | 71 | 21-09-20 |
Chief Tech/Sci/R&D Officer | 63 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 22-09-30 | |
Thomas Jensen
FOU | Founder | 46 | 20-05-31 |
Joseph Vazzano
BRD | Director/Board Member | 40 | 23-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.7562 | +3.21% | 2 320 821 |
24-05-07 | 0.7327 | -18.68% | 8,060,476 |
24-05-06 | 0.901 | -9.90% | 21,050,921 |
24-05-03 | 1 | -18.70% | 7,555,562 |
24-05-02 | 1.23 | -10.22% | 94,380,092 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.35% | 226K | |
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- ALLR Stock